Copyright Reports & Markets. All rights reserved.

Global and United States Aprepitant Capsules Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Aprepitant Capsules Product Introduction
    • 1.2 Global Aprepitant Capsules Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Aprepitant Capsules Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Aprepitant Capsules Sales in Volume for the Year 2017-2028
    • 1.3 United States Aprepitant Capsules Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Aprepitant Capsules Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Aprepitant Capsules Sales in Volume for the Year 2017-2028
    • 1.4 Aprepitant Capsules Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Aprepitant Capsules in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Aprepitant Capsules Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Aprepitant Capsules Market Dynamics
      • 1.5.1 Aprepitant Capsules Industry Trends
      • 1.5.2 Aprepitant Capsules Market Drivers
      • 1.5.3 Aprepitant Capsules Market Challenges
      • 1.5.4 Aprepitant Capsules Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Aprepitant Capsules Market Segment by Type
      • 2.1.1 80mg
      • 2.1.2 125mg
      • 2.1.3 Other
    • 2.2 Global Aprepitant Capsules Market Size by Type
      • 2.2.1 Global Aprepitant Capsules Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Aprepitant Capsules Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Aprepitant Capsules Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Aprepitant Capsules Market Size by Type
      • 2.3.1 United States Aprepitant Capsules Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Aprepitant Capsules Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Aprepitant Capsules Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Aprepitant Capsules Market Segment by Application
      • 3.1.1 Hospital
      • 3.1.2 Pharmacy
      • 3.1.3 Other
    • 3.2 Global Aprepitant Capsules Market Size by Application
      • 3.2.1 Global Aprepitant Capsules Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Aprepitant Capsules Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Aprepitant Capsules Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Aprepitant Capsules Market Size by Application
      • 3.3.1 United States Aprepitant Capsules Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Aprepitant Capsules Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Aprepitant Capsules Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Aprepitant Capsules Competitor Landscape by Company

    • 4.1 Global Aprepitant Capsules Market Size by Company
      • 4.1.1 Top Global Aprepitant Capsules Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Aprepitant Capsules Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Aprepitant Capsules Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Aprepitant Capsules Price by Manufacturer (2017-2022)
    • 4.2 Global Aprepitant Capsules Concentration Ratio (CR)
      • 4.2.1 Aprepitant Capsules Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Aprepitant Capsules in 2021
      • 4.2.3 Global Aprepitant Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Aprepitant Capsules Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Aprepitant Capsules Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Aprepitant Capsules Product Type
      • 4.3.3 Date of International Manufacturers Enter into Aprepitant Capsules Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Aprepitant Capsules Market Size by Company
      • 4.5.1 Top Aprepitant Capsules Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Aprepitant Capsules Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Aprepitant Capsules Sales by Players (2020, 2021 & 2022)

    5 Global Aprepitant Capsules Market Size by Region

    • 5.1 Global Aprepitant Capsules Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Aprepitant Capsules Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Aprepitant Capsules Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Aprepitant Capsules Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Aprepitant Capsules Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Aprepitant Capsules Sales in Value by Region: 2017-2022
      • 5.3.2 Global Aprepitant Capsules Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Aprepitant Capsules Market Size YoY Growth 2017-2028
      • 6.1.2 North America Aprepitant Capsules Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Aprepitant Capsules Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Aprepitant Capsules Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Aprepitant Capsules Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Aprepitant Capsules Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Aprepitant Capsules Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Aprepitant Capsules Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
      • 6.4.6 Colombia
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Aprepitant Capsules Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Aprepitant Capsules Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Merck
      • 7.1.1 Merck Corporation Information
      • 7.1.2 Merck Description and Business Overview
      • 7.1.3 Merck Aprepitant Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Merck Aprepitant Capsules Products Offered
      • 7.1.5 Merck Recent Development
    • 7.2 Sandoz
      • 7.2.1 Sandoz Corporation Information
      • 7.2.2 Sandoz Description and Business Overview
      • 7.2.3 Sandoz Aprepitant Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 Sandoz Aprepitant Capsules Products Offered
      • 7.2.5 Sandoz Recent Development
    • 7.3 Glenmark Pharmaceuticals
      • 7.3.1 Glenmark Pharmaceuticals Corporation Information
      • 7.3.2 Glenmark Pharmaceuticals Description and Business Overview
      • 7.3.3 Glenmark Pharmaceuticals Aprepitant Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 Glenmark Pharmaceuticals Aprepitant Capsules Products Offered
      • 7.3.5 Glenmark Pharmaceuticals Recent Development
    • 7.4 Chia Tai Tianqing Pharmaceutical Group
      • 7.4.1 Chia Tai Tianqing Pharmaceutical Group Corporation Information
      • 7.4.2 Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
      • 7.4.3 Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Products Offered
      • 7.4.5 Chia Tai Tianqing Pharmaceutical Group Recent Development
    • 7.5 Qilu Pharmaceutical
      • 7.5.1 Qilu Pharmaceutical Corporation Information
      • 7.5.2 Qilu Pharmaceutical Description and Business Overview
      • 7.5.3 Qilu Pharmaceutical Aprepitant Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Qilu Pharmaceutical Aprepitant Capsules Products Offered
      • 7.5.5 Qilu Pharmaceutical Recent Development
    • 7.6 Camber Pharma
      • 7.6.1 Camber Pharma Corporation Information
      • 7.6.2 Camber Pharma Description and Business Overview
      • 7.6.3 Camber Pharma Aprepitant Capsules Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 Camber Pharma Aprepitant Capsules Products Offered
      • 7.6.5 Camber Pharma Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Aprepitant Capsules Industry Chain Analysis
    • 8.2 Aprepitant Capsules Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Aprepitant Capsules Distributors
    • 8.3 Aprepitant Capsules Production Mode & Process
    • 8.4 Aprepitant Capsules Sales and Marketing
      • 8.4.1 Aprepitant Capsules Sales Channels
      • 8.4.2 Aprepitant Capsules Distributors
    • 8.5 Aprepitant Capsules Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:

      Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
      Market Analysis and Insights: Global and United States Aprepitant Capsules Market
      This report focuses on global and United States Aprepitant Capsules market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Aprepitant Capsules market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, 80mg accounting for % of the Aprepitant Capsules global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Aprepitant Capsules market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
      Global Aprepitant Capsules Scope and Market Size
      Aprepitant Capsules market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Aprepitant Capsules market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Aprepitant Capsules market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Aprepitant Capsules market is segmented into
      80mg
      125mg
      Other
      Segment by Application, the Aprepitant Capsules market is segmented into
      Hospital
      Pharmacy
      Other
      Regional and Country-level Analysis
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Aprepitant Capsules Market Share Analysis
      Aprepitant Capsules market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Aprepitant Capsules business, the date to enter into the Aprepitant Capsules market, Aprepitant Capsules product introduction, recent developments, etc.
      The major vendors covered:
      Merck
      Sandoz
      Glenmark Pharmaceuticals
      Chia Tai Tianqing Pharmaceutical Group
      Qilu Pharmaceutical
      Camber Pharma
      Buy now